Severe pregnancy sickness drives Welsh woman toward sterilisation
A 26-year-old from Newport with hyperemesis gravidarum says extreme pregnancy sickness nearly forced an abortion and she is now pursuing sterilisation after finding access to Xonvea, an anti-sickness drug not routinely funded in Wales, difficult; campaigners argue the drug’s cost is offset by reduced hospitalisations, while AWMSG has not approved routine use due to cost-effectiveness concerns. GPs can prescribe Xonvea in certain cases, and its price is £28.50 for a 20‑tablet box; the drug’s limited availability has spurred calls for broader access as patients and doctors weigh future pregnancy decisions.